Recombinant Human VSIG2 Protein，His

VSIG2 (V-set and immunoglobulin domain containing 2) is a member of the immunoglobulin superfamily and plays a significant role in immune regulation. It is primarily expressed in immune cells, such as T cells and dendritic cells, and has been implicated in various biological processes, including cell adhesion, signaling, and immune response modulation. Research has shown that VSIG2 is involved in controlling the balance between immune activation and tolerance, making it a crucial factor in autoimmune diseases and cancer immunotherapy. Given its emerging significance in immunology, scientists have increasingly focused on understanding the structure and function of VSIG2, especially in the context of its role as a potential therapeutic target. Recent studies have employed techniques such as gene editing, protein expression, and crystal structure analysis to elucidate the mechanisms by which VSIG2 interacts with other immune components. These investigations aim not only to clarify its function in immune modulation but also to explore its potential applicability in developing novel treatment strategies for immune-related conditions. As the scientific community continues to uncover the intricate roles of immune receptors like VSIG2, a deeper understanding of its structure-function relationship may pave the way for innovative approaches in immunotherapy, ultimately contributing to improved outcomes in autoimmune diseases and cancer. The ongoing research into VSIG2 thus represents a promising avenue for advancing our knowledge of immune regulation and therapeutic interventions.